POSITRON EMISSION TOMOGRAPHY-EVALUATION OF DOPAMINERGIC PATHWAYS

被引：0
|
作者：
PERLMUTTER, JS [1 ]
机构：
[1] WASHINGTON UNIV,SCH MED,DEPT NEUROL & NEUROL SURG NEUROL,ST LOUIS,MO
来源：
CLINICAL NEUROPHARMACOLOGY | 1995年 / 18卷
关键词：
POSITRON EMISSION TOMOGRAPHY; DOPAMINE; PARKINSONS DISEASE; RECEPTORS; TRANSMITTERS;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Positron emission tomography (PET) studies of dopamine receptors have provided exciting new insights into basal ganglia function that are particularly relevant to Parkinson's disease. Previous studies have concentrated on alterations in radioligand binding of primarily D-2-like dopaminergic binding sites. Development of new radioligands with greater dopamine subtype specificity promises to reveal additional information about dopaminergic function. Also, pharmacological activation techniques with PET may permit identification of alterations in receptor-mediated pathways not associated with direct changes in receptors.
引用
收藏
页码：S188 / S194
页数：7
相关论文
共 50 条
  • [1] DOPAMINERGIC PATHWAYS IN HUMANS STUDIED BY POSITRON EMISSION TOMOGRAPHY
    MARTIN, WRW
    STOESSL, J
    ADAM, MJ
    RUTH, TJ
    CALNE, DB
    PATE, BD
    ANNALS OF NEUROLOGY, 1985, 18 (01) : 118 - 118
  • [2] CENTRAL DOPAMINERGIC PATHWAYS IN HEMIPARKINSONISM EXAMINED BY POSITRON EMISSION TOMOGRAPHY
    GARNETT, ES
    NAHMIAS, C
    FIRNAU, G
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 174 - 179
  • [3] POSITRON EMISSION TOMOGRAPHY-EVALUATION OF MYOCARDIAL DYSFUNCTION AFTER THE ARTERIAL SWITCH OPERATION IN INFANTS
    ALLADA, V
    BRUNKEN, RC
    HURWITZ, RA
    LAKS, H
    WILLIAMS, RG
    JARMAKANI, JM
    SCHELBERT, HR
    CIRCULATION, 1994, 90 (04) : 531 - 531
  • [4] POSITRON EMISSION TOMOGRAPHY-EVALUATION OF THE ACTION OF L-CARNITINE ON HUMAN MYOCARDIAL-METABOLISM
    DUBOC, D
    SYROTA, A
    JOUAS, M
    CROUZEL, C
    GUERIN, F
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 140 - 140
  • [5] POSITRON EMISSION TOMOGRAPHY (PET) FOR THE EVALUATION OF DOPAMINERGIC AND CHOLINERGIC MECHANISMS IN THE BRAIN
    AQUILONIUS, SM
    ECKERNAS, SA
    BERGSTROM, K
    HARTVIG, P
    HAGGLUND, J
    LUNDQVIST, H
    LANGSTROM, B
    MALMBORG, P
    ACTA NEUROLOGICA SCANDINAVICA, 1985, 72 (02): : 226 - 226
  • [6] POSITRON EMISSION TOMOGRAPHY IN DEGENERATIVE DISORDERS OF THE DOPAMINERGIC SYSTEM
    KARBE, H
    HOLTHOFF, V
    HUBER, M
    HERHOLZ, K
    WIENHARD, K
    WAGNER, R
    HEISS, WD
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1992, 4 (02) : 121 - 130
  • [7] Evaluation of the dopaminergic system with positron-emission tomography in alcohol abuse: A systematic review
    Manenti Alexandre, Maria Cecilia
    Colonetti, Tamy
    Bavaresco, Daniela V.
    Simon, Carla Sasso
    Dondossola, Eduardo Ronconi
    Rodrigues Uggioni, Maria Laura
    Ferraz, Sarah Dagostin
    Rico, Eduardo Pacheco
    da Rosa, Maria Ines
    PSYCHIATRY RESEARCH, 2019, 281
  • [8] F-18 LABELED VESAMICOL DERIVATIVES - SYNTHESES AND PRELIMINARY IN-VIVO SMALL ANIMAL POSITRON EMISSION TOMOGRAPHY-EVALUATION
    ROGERS, GA
    STONEELANDER, S
    INGVAR, M
    ERIKSSON, L
    PARSONS, SM
    WIDEN, L
    NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (02): : 219 - 230
  • [9] Dopaminergic Activity in Depressed Smokers: A Positron Emission Tomography Study
    Busto, Usoa E.
    Redden, Laura
    Mayberg, Helen
    Kapur, Shitij
    Houle, Sylvain
    Zawertailo, Laurie A.
    SYNAPSE, 2009, 63 (08) : 681 - 689
  • [10] Positron emission tomography in the evaluation of lymphoma
    Israel, O
    Keidar, Z
    Bar-Shalom, R
    SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (03) : 166 - 179
12345